Search research articles
Contact Us
Filters
Showing results (11-20 of 25) with videos related to
Page
of 3
Sort By:
Cell Death and Differentiation
|
March 29, 2024
ZBP1 and TRIF trigger lethal necroptosis in mice lacking caspase-8 and TNFR1
Margaret Solon, Nianfeng Ge, Shannon Hambro, et al.
Iscience
|
December 1, 2025
Transcription factor Zfx regulates tumor's evasion to T cell killing in immunotherapy
Ulrike Kaufmann, Joy Wang, Marinella G Callow, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology
|
February 11, 2026
Characterization of an anti-STEAP1 T-Cell Dependent Bispecific Antibody for the Treatment of Prostate Cancer and Associated Toxicity in Cynomolgus Monkeys
Elizabeth G Tonkin, Michelle Lepherd, John Davies, et al.
Human Molecular Genetics
|
June 11, 2013
Blood RNA profiling in a large cohort of multiple sclerosis patients and healthy controls
Dorothee Nickles, Hsuan P Chen, Michael M Li, et al.
Clinical Immunology (Orlando, Fla.)
|
February 6, 2014
The autoimmune disease-associated transcription factors EOMES and TBX21 are dysregulated in multiple sclerosis and define a molecular subtype of disease
Grant P Parnell, Prudence N Gatt, Malgorzata Krupa, et al.
Immunity
|
October 23, 2012
A PP4 holoenzyme balances physiological and oncogenic nuclear factor-kappa B signaling in T lymphocytes
Markus Brechmann, Thomas Mock, Dorothee Nickles, et al.
Cancer Immunology Research
|
May 9, 2019
Coexpression of Inhibitory Receptors Enriches for Activated and Functional CD8<sup>+</sup> T Cells in Murine Syngeneic Tumor Models
Huizhong Xiong, Stephanie Mittman, Ryan Rodriguez, et al.
Cell Death and Differentiation
|
March 3, 2019
Therapeutic resistance and susceptibility is shaped by cooperative multi-compartment tumor adaptation
Jason E Long, Matthew J Wongchenko, Dorothee Nickles, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 20, 2020
NRF2 Activation Promotes Aggressive Lung Cancer and Associates with Poor Clinical Outcomes
Anju Singh, Anneleen Daemen, Dorothee Nickles, et al.
Nature Communications
|
June 26, 2021
Molecular determinants of response to PD-L1 blockade across tumor types
Romain Banchereau, Ning Leng, Oliver Zill, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 25) with videos related to
Sort By:
Page
of 3
Cell Death and Differentiation
|
March 29, 2024
ZBP1 and TRIF trigger lethal necroptosis in mice lacking caspase-8 and TNFR1
Margaret Solon, Nianfeng Ge, Shannon Hambro, et al.
Iscience
|
December 1, 2025
Transcription factor Zfx regulates tumor's evasion to T cell killing in immunotherapy
Ulrike Kaufmann, Joy Wang, Marinella G Callow, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology
|
February 11, 2026
Characterization of an anti-STEAP1 T-Cell Dependent Bispecific Antibody for the Treatment of Prostate Cancer and Associated Toxicity in Cynomolgus Monkeys
Elizabeth G Tonkin, Michelle Lepherd, John Davies, et al.
Human Molecular Genetics
|
June 11, 2013
Blood RNA profiling in a large cohort of multiple sclerosis patients and healthy controls
Dorothee Nickles, Hsuan P Chen, Michael M Li, et al.
Clinical Immunology (Orlando, Fla.)
|
February 6, 2014
The autoimmune disease-associated transcription factors EOMES and TBX21 are dysregulated in multiple sclerosis and define a molecular subtype of disease
Grant P Parnell, Prudence N Gatt, Malgorzata Krupa, et al.
Immunity
|
October 23, 2012
A PP4 holoenzyme balances physiological and oncogenic nuclear factor-kappa B signaling in T lymphocytes
Markus Brechmann, Thomas Mock, Dorothee Nickles, et al.
Cancer Immunology Research
|
May 9, 2019
Coexpression of Inhibitory Receptors Enriches for Activated and Functional CD8<sup>+</sup> T Cells in Murine Syngeneic Tumor Models
Huizhong Xiong, Stephanie Mittman, Ryan Rodriguez, et al.
Cell Death and Differentiation
|
March 3, 2019
Therapeutic resistance and susceptibility is shaped by cooperative multi-compartment tumor adaptation
Jason E Long, Matthew J Wongchenko, Dorothee Nickles, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 20, 2020
NRF2 Activation Promotes Aggressive Lung Cancer and Associates with Poor Clinical Outcomes
Anju Singh, Anneleen Daemen, Dorothee Nickles, et al.
Nature Communications
|
June 26, 2021
Molecular determinants of response to PD-L1 blockade across tumor types
Romain Banchereau, Ning Leng, Oliver Zill, et al.
Page
of 3